4.7 Article

Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy

Pirkka-Pekka Laurila et al.

Summary: Inhibition of sphingolipid synthesis, targeting multiple pathogenic pathways, shows promise as a potential treatment for muscular dystrophies.

SCIENCE ADVANCES (2022)

Review Pediatrics

Gene therapy for neuromuscular disorders: prospects and ethics

Monique M. Ryan

Summary: Most childhood neuromuscular disorders are caused by mutations in single genes, and gene therapies have potential to improve these conditions. However, challenges such as safety and cost must be carefully assessed. International variations in treatment and rehabilitation will affect equity of access, which will require collaboration to address safety and cost issues.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Article Multidisciplinary Sciences

Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy

Anirban Roy et al.

Summary: The study reveals that supraphysiological activation of TAK1 can promote muscle hypertrophy through the regulation of eIF4E, and prevent denervation-induced muscle atrophy. This finding highlights the important role of TAK1 in skeletal muscle growth and maintenance.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy

Justin G. Boyer et al.

Summary: Satellite cells play a crucial role in the progression of muscular dystrophy, and their depletion can improve the pathology and muscle performance in dystrophic mouse models. Mechanistically, satellite cells initiate the expression of MyoD, which induces the re-expression of fetal genes in myofibers, leading to sarcolemmal destabilization. These findings suggest that satellite cell activation and the fetal gene program are maladaptive in chronic muscular dystrophy.

NATURE COMMUNICATIONS (2022)

Article Clinical Neurology

Gene Therapy for Duchenne Muscular Dystrophy

Nertiyan Elangkovan et al.

Journal of Neuromuscular Diseases (2021)

Review Multidisciplinary Sciences

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease

Roberta Sartori et al.

Summary: Skeletal muscle acts as a protein reservoir in the body and plays a key role in regulating glucose and lipid levels. The growth or loss of muscle mass can impact overall metabolism, movement, eating, and breathing. Various quality systems control muscle function, adapting cells to environmental and nutritional cues.

NATURE COMMUNICATIONS (2021)

Article Geriatrics & Gerontology

TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy

Dengqiu Xu et al.

Summary: This study found that TAK1 activation worsens fibrosis and muscle degeneration, while TAK1 inhibition can improve muscle quality and function, providing a potential new therapeutic approach for DMD.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Review Clinical Neurology

Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New

Samuel J. Mackenzie et al.

Summary: Duchenne muscular dystrophy is caused by pathogenic variants in the DMD gene, and treatment options include the use of corticosteroids like prednisone, gene replacement therapy, and RNA strategies. Novel therapeutic approaches offer hope for treating this devastating disease.

SEMINARS IN PEDIATRIC NEUROLOGY (2021)

Article Medicine, General & Internal

Duchenne muscular dystrophy

Dongsheng Duan et al.

Summary: Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the DMD gene, leading to loss of muscle tissue and function as well as cardiomyopathy. Recent studies have deepened understanding of the disease and led to the development of multidisciplinary care guidelines and various therapeutic approaches.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Biotechnology & Applied Microbiology

CRISPR technologies for the treatment of Duchenne muscular dystrophy

Eunyoung Choi et al.

Summary: The CRISPR-Cas system shows potential in treating Duchenne muscular dystrophy (DMD), but challenges in developing more efficient therapeutic approaches and delivery methods remain.

MOLECULAR THERAPY (2021)

Article Cell Biology

Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy

Peiling Luan et al.

Summary: Research shows that decreased mitochondrial autophagy may contribute to mitochondrial dysfunction in Duchenne muscular dystrophy (DMD) patients and experimental models. However, administration of the mitophagy activator urolithin A can improve mitochondrial function and alleviate symptoms of DMD, suggesting potential therapeutic applications for muscular dystrophies.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy

Giorgia Careccia et al.

Summary: This study identified the important role of high-mobility group box 1 (HMGB1) in muscular dystrophies (MDs), where HMGB1 oxidation is a detrimental process. Treatment with a non-oxidizable variant of HMGB1 improves the phenotype of MDs.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy

Theresa M. Raimondo et al.

Summary: Chronic inflammation plays a role in muscular dystrophies, with anti-inflammatory cytokine treatment shown to increase T-reg recruitment, muscle fiber area, contraction force, and velocity, offering potential benefits for diverse muscular dystrophies.

SCIENCE ADVANCES (2021)

Review Medicine, Research & Experimental

p38 MAPKs - roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets

Christopher M. Brennan et al.

Summary: p38 MAPKs play a central role in cellular response, myogenesis, and disease progression, making them potential targets for therapeutic intervention. Targeting p38 MAPKs may help in treating diseases like facioscapulohumeral muscular dystrophy.

JCI INSIGHT (2021)

Review Biochemistry & Molecular Biology

The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene

Eric P. Hoffman

FEBS JOURNAL (2020)

Article Medicine, Research & Experimental

TGF-β-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model

Davi A. G. Mazala et al.

JCI INSIGHT (2020)

Article Biochemistry & Molecular Biology

TAK1 preserves skeletal muscle mass and mitochondrial function through redox homeostasis

Anirban Roy et al.

FASEB BIOADVANCES (2020)

Article Biochemistry & Molecular Biology

MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice

Yann S. Gallot et al.

HUMAN MOLECULAR GENETICS (2018)

Article Multidisciplinary Sciences

Necroptosis mediates myofibre death in dystrophin-deficient mice

Jennifer E. Morgan et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

TAK1 regulates skeletal muscle mass and mitochondrial function

Sajedah M. Hindi et al.

JCI INSIGHT (2018)

Article Multidisciplinary Sciences

Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis

Jiefei Geng et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair

Yuji Ogura et al.

NATURE COMMUNICATIONS (2015)

Article Physiology

The Dystrophin Complex: Structure, Function, and Implications for Therapy

Quan Q. Gao et al.

COMPREHENSIVE PHYSIOLOGY (2015)

Review Biochemistry & Molecular Biology

TAK1 control of cell death

S. R. Mihaly et al.

CELL DEATH AND DIFFERENTIATION (2014)

Article Biochemistry & Molecular Biology

Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice

Aiping Lu et al.

HUMAN MOLECULAR GENETICS (2014)

Article Biochemistry & Molecular Biology

P38α MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism

Erin R. Wissing et al.

HUMAN MOLECULAR GENETICS (2014)

Review Cell Biology

Cellular and molecular mechanisms of muscle atrophy

Paolo Bonaldo et al.

DISEASE MODELS & MECHANISMS (2013)

Article Medicine, Research & Experimental

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects

Christopher R. Heier et al.

EMBO MOLECULAR MEDICINE (2013)

Review Biochemistry & Molecular Biology

Wasting mechanisms in muscular dystrophy

Jonghyun Shin et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)

Article Biochemistry & Molecular Biology

The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-Induced Skeletal Muscle Atrophy through Multiple Mechanisms

Pradyut K. Paul et al.

MOLECULAR AND CELLULAR BIOLOGY (2012)

Review Urology & Nephrology

TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis

Mary E. Choi et al.

SEMINARS IN NEPHROLOGY (2012)

Article Cell Biology

Autophagy as a new therapeutic target in Duchenne muscular dystrophy

C. De Palma et al.

CELL DEATH & DISEASE (2012)

Article Pathology

Genetic Background Affects Properties of Satellite Cells and mdx Phenotypes

So-ichiro Fukada et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Review Genetics & Heredity

Therapeutic targeting of signaling pathways in muscular dystrophy

Shephali Bhatnagar et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2010)

Article Cell Biology

Autophagy Is Required to Maintain Muscle Mass

Eva Masiero et al.

CELL METABOLISM (2009)

Review Genetics & Heredity

Nuclear factor-kappa B signaling in skeletal muscle atrophy

Hong Li et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2008)

Article Medicine, Research & Experimental

Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

Swarnali Acharyya et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Review Physiology

Function and genetics of dystrophin and dystrophin-related proteins in muscle

DJ Blake et al.

PHYSIOLOGICAL REVIEWS (2002)

Article Multidisciplinary Sciences

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

C Wang et al.

NATURE (2001)

Article Medicine, Research & Experimental

T-cell-dependent fibrosis in the mdx dystrophic mouse

J Morrison et al.

LABORATORY INVESTIGATION (2000)

Article Biochemistry & Molecular Biology

TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop

K Kishimoto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)